Search Results

Select Medical Holdings Corporation, will release the financial results for its second quarter ended June 30, 2024 on Thursday, August 1, 2024 after the market closes.

Select Medical Holdings Corporation announced results for its first quarter ended March 31, 2024, and the declaration of a cash dividend.

Select Medical Holdings Corporation, will release the financial results for its first quarter ended March 31, 2024 on Thursday, May 2, 2024 after the market closes.

SeaStar Medical Holding Corporation announces the publication of a peer-reviewed article in NatureScientific Reports that describes the mechanism of action of the Company’s Selective Cytopheretic Device in the immunomodulation of excessive inflammation.

Select Medical Holdings Corporation announced that its board of directors has approved a plan to pursue the separation of Select Medical’s wholly-owned occupational health services business, Concentra Group Holdings Parent, LLC.

SeaStar Medical Holding Corporation announces the publication of a manuscript citing four case studies in which critically ill patients between the ages of 22 months and 71 years with multiorgan failure who were treated with the Selective Cytopheretic Device successfully stabilized and improved their clinical status prior to stem cell or liver transplant, or left ventricular assist device implantation.